ReviewCNS drugs2015
Epidemiology and management of neuropsychiatric disorders in Behçet's syndrome.
Review in CNS drugs, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 25 citations in OpenAlex.
- Neuro-Behçet's Disease and Psychiatric Disorders: From a Case Report to a Systematic Review.Brain and behavior · 2026Pooled it
- Sleep quality in Behçet's disease: a systematic literature review.Rheumatology international · 2023Pooled it
- Sexual dysfunction in Behçet's syndrome.Rheumatology international · 2020Pooled it
- Article
- Unraveling the psychological burden of Behçet disease: the impact of anxiety and depression on health-related quality of life outcomes.Orphanet journal of rare diseases · 2026Article
- Assessing disease phenotypes in Behçet's syndrome: insights from a multiple correspondence analysis.Frontiers in immunology · 2025Article
- A cost-of-illness study of Behçet syndrome in Italy.The European journal of health economics : HEPAC : health economics in prevention and care · 2024Review
- Investigation of Biopsychosocial Status, Fatigue, Sleep Quality, Alexithymia, Cognitive Functions, and Quality of Life in Behçet's Disease.Mediterranean journal of rheumatology · 2023Article
- Exploring disease perception in Behçet's syndrome: combining a quantitative and a qualitative study based on a narrative medicine approach.Orphanet journal of rare diseases · 2023Article
- Being a caregiver of a Behçet's syndrome patient: challenges and perspectives during a complex journey.Orphanet journal of rare diseases · 2021Article
- Empowering Patients in the Therapeutic Decision-Making Process: A Glance Into Behçet's Syndrome.Frontiers in medicine · 2021Article
- Identification of physical and psychosocial problems based on symptoms in patients with Behçet's disease.Rheumatology international · 2020Article
- "Neuro-psycho- BS": A Case Report of Rare Association with Bipolar Disorder.Shanghai archives of psychiatry · 2018Article
- Psychosis: an autoimmune disease?Immunology · 2017Review
- Neurological complications of Behçet's syndrome.Journal of neurology · 2017Review
- Neuro-Psycho-Behçet or Neuropsychiatric Behçet Disease: A Modified Name for an Old Disease.Noro psikiyatri arsivi · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Behçet's syndrome (BS) is a systemic, chronic, relapsing vasculitis, typically characterized by recurrent orogenital ulcers, ocular inflammation and skin manifestations; articular, vascular, gastroenteric and neurological involvement may also occur. Besides the other clinical features of BS, it seems relatively frequent that patients with BS develop a neurobehavioural syndrome, characterized by euphoria, bipolar disorders and paranoid attitudes, loss of insight/disinhibition, and indifference to their disease, defined as 'neuro-psycho-BS'. To date, the pathogenetic mechanism underlying neuro-psycho-BS has not been determined. It may be secondary to organic neurological involvement, or it may be related to poor quality of life and the relapsing course of the disease. Another engaging theory suggests that it could be related to the frequent observation of psychiatric symptoms during relapses or, in some cases, in the phases preceding reactivation of the disease; these elements suggest that psychiatric disorders in BS could represent a crucial element, whether a psychiatric subset or a distinct clinical feature of the disease. Moreover, it has been reported that cognitive impairment in BS can be seen with or without central nervous system involvement. Globally, psychiatric symptoms have been described as being multifaceted, ranging from anxiety disorders to depressive-bipolar disorders or to psychotic ones. In addition, some psychological characteristics of BS patients seem to predispose them to maladaptive stress management, which may lead to stress-related disorders, including anxiety and depression. Therefore, the aims of this review are to explore the epidemiology of neuro-psycho-BS by evaluating the relationship between the stress system and the multifaceted psychiatric manifestations in BS, and to summarize the therapeutic strategy used.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.